Fezolinetant

Fezolinetant is a medication used to treat moderate to severe vasomotor symptoms (hot flashes and night sweats) associated with menopause. It is a selective neurokinin-3 (NK3) receptor antagonist. These receptors are involved in the regulation of body temperature, and their activity is believed to be altered during menopause, contributing to the occurrence of hot flashes.

Fezolinetant works by blocking the action of neurokinin B (NKB) at the NK3 receptor in the hypothalamus, a region of the brain that plays a key role in thermoregulation. By inhibiting this pathway, fezolinetant helps to stabilize the body's temperature control mechanisms, thereby reducing the frequency and severity of hot flashes.

The drug is administered orally and is typically taken once a day. Clinical trials have demonstrated its efficacy in reducing both the frequency and severity of moderate to severe vasomotor symptoms in menopausal women. It is generally considered safe and well-tolerated, although common side effects may include diarrhea, insomnia, and upper abdominal pain.

Fezolinetant represents a non-hormonal option for managing menopausal hot flashes, offering an alternative for individuals who cannot or prefer not to use hormone therapy. Its development marks a significant advancement in the pharmacological treatment of menopausal symptoms.